These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24532584)

  • 1. Zhankuic acid A isolated from Taiwanofungus camphoratus is a novel selective TLR4/MD-2 antagonist with anti-inflammatory properties.
    Chen YF; Shiau AL; Wang SH; Yang JS; Chang SJ; Wu CL; Wu TS
    J Immunol; 2014 Mar; 192(6):2778-86. PubMed ID: 24532584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zhankuic acid A as a novel JAK2 inhibitor for the treatment of concanavalin A-induced hepatitis.
    Chen YF; Wang SH; Chang SJ; Shiau AL; Her LS; Shieh GS; Chen CF; Chang CC; Su YC; Wu CL; Wu TS
    Biochem Pharmacol; 2014 Sep; 91(2):217-30. PubMed ID: 25076381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway
    Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex.
    Mishra V; Pathak C
    J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppressive effect of zhankuic acid C from Taiwanofungus camphoratus on dendritic cell activation and the contact hypersensitivity response.
    Lin MK; Lee MS; Chang WT; Chen HY; Chen JF; Li YR; Lin CC; Wu TS
    Bioorg Med Chem Lett; 2015 Oct; 25(20):4637-41. PubMed ID: 26338360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
    Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
    J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran.
    Kim HM; Park BS; Kim JI; Kim SE; Lee J; Oh SC; Enkhbayar P; Matsushima N; Lee H; Yoo OJ; Lee JO
    Cell; 2007 Sep; 130(5):906-17. PubMed ID: 17803912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partially glycosylated dendrimers block MD-2 and prevent TLR4-MD-2-LPS complex mediated cytokine responses.
    Barata TS; Teo I; Brocchini S; Zloh M; Shaunak S
    PLoS Comput Biol; 2011 Jun; 7(6):e1002095. PubMed ID: 21738462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling.
    Yang H; Wang H; Ju Z; Ragab AA; Lundbäck P; Long W; Valdes-Ferrer SI; He M; Pribis JP; Li J; Lu B; Gero D; Szabo C; Antoine DJ; Harris HE; Golenbock DT; Meng J; Roth J; Chavan SS; Andersson U; Billiar TR; Tracey KJ; Al-Abed Y
    J Exp Med; 2015 Jan; 212(1):5-14. PubMed ID: 25559892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gedunin Binds to Myeloid Differentiation Protein 2 and Impairs Lipopolysaccharide-Induced Toll-Like Receptor 4 Signaling in Macrophages.
    Borges PV; Moret KH; Maya-Monteiro CM; Souza-Silva F; Alves CR; Batista PR; Caffarena ER; Pacheco P; Henriques Md; Penido C
    Mol Pharmacol; 2015 Nov; 88(5):949-61. PubMed ID: 26330549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2.
    Ohto U; Fukase K; Miyake K; Shimizu T
    Proc Natl Acad Sci U S A; 2012 May; 109(19):7421-6. PubMed ID: 22532668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-inflammatory effect of procyanidin B1 on LPS-treated THP1 cells via interaction with the TLR4-MD-2 heterodimer and p38 MAPK and NF-κB signaling.
    Xing J; Li R; Li N; Zhang J; Li Y; Gong P; Gao D; Liu H; Zhang Y
    Mol Cell Biochem; 2015 Sep; 407(1-2):89-95. PubMed ID: 26037075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential roles of hydrophobic residues in both MD-2 and toll-like receptor 4 in activation by endotoxin.
    Resman N; Vasl J; Oblak A; Pristovsek P; Gioannini TL; Weiss JP; Jerala R
    J Biol Chem; 2009 May; 284(22):15052-60. PubMed ID: 19321453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized TLR4/MD-2 mice reveal LPS recognition differentially impacts susceptibility to Yersinia pestis and Salmonella enterica.
    Hajjar AM; Ernst RK; Fortuno ES; Brasfield AS; Yam CS; Newlon LA; Kollmann TR; Miller SI; Wilson CB
    PLoS Pathog; 2012; 8(10):e1002963. PubMed ID: 23071439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis of Artemisinin Derivatives Inhibition of Myeloid Differentiation Protein 2 by Combined in Silico and Experimental Study.
    Qiao S; Zhang H; Sun F; Jiang Z
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex.
    Park BS; Song DH; Kim HM; Choi BS; Lee H; Lee JO
    Nature; 2009 Apr; 458(7242):1191-5. PubMed ID: 19252480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid differentiation protein 2 silencing decreases LPS-induced cytokine production and TLR4/MyD88 pathway activity in alveolar macrophages.
    Ren W; Hu L; Hua F; Jin J; Wang Y; Zhu L
    Immunol Lett; 2011 Dec; 141(1):94-101. PubMed ID: 21849156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-endotoxic activity and structural basis for human MD-2·TLR4 antagonism of tetraacylated lipid A mimetics based on βGlcN(1↔1)αGlcN scaffold.
    Garate JA; Stöckl J; Fernández-Alonso Mdel C; Artner D; Haegman M; Oostenbrink C; Jiménez-Barbero J; Beyaert R; Heine H; Kosma P; Zamyatina A
    Innate Immun; 2015 Jul; 21(5):490-503. PubMed ID: 25394365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactions.
    Joce C; Stahl JA; Shridhar M; Hutchinson MR; Watkins LR; Fedichev PO; Yin H
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5411-3. PubMed ID: 20709548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of endotoxin responses is achieved by targeting the TLR4 coreceptor, MD-2.
    Visintin A; Halmen KA; Latz E; Monks BG; Golenbock DT
    J Immunol; 2005 Nov; 175(10):6465-72. PubMed ID: 16272300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.